Found: 11
Select item for more details and to access through your institution.
A phase I-II study of docetaxel-ifosfamide-cisplatin (DIP) combination chemotherapy regimen in advanced nonsmall cell lung cancer.
- Published in:
- International Journal of Cancer, 2002, v. 98, n. 1, p. 141, doi. 10.1002/ijc.10162
- By:
- Publication type:
- Article
The Role of Low-dose Anti-thymocyte Globulin as Standard Prophylaxis in Mismatched and Matched Unrelated Hematopoietic Peripheral Stem Cell Transplantation for Hematologic Malignancies.
- Published in:
- 2017
- By:
- Publication type:
- journal article
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1097942
- By:
- Publication type:
- Article
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 01, doi. 10.3389/fonc.2023.1097942
- By:
- Publication type:
- Article
Clonal haematopoiesis as a risk factor for therapy‐related myeloid neoplasms in patients with chronic lymphocytic leukaemia treated with chemo‐(immuno)therapy.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 1, p. 103, doi. 10.1111/bjh.18129
- By:
- Publication type:
- Article
DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy.
- Published in:
- Clinical Epigenetics, 2019, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13148-019-0783-1
- By:
- Publication type:
- Article
The Calcitriol/Vitamin D Receptor System Regulates Key Immune Signaling Pathways in Chronic Lymphocytic Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 2, p. 285, doi. 10.3390/cancers13020285
- By:
- Publication type:
- Article
Real‐life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B‐cell lymphomas.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 336, doi. 10.1002/hon.2842
- By:
- Publication type:
- Article
Brentuximab vedotin and anti-PD1 treatment optimize survival in chemo-refractory Hodgkin lymphoma patients: Real-world data.
- Published in:
- 2019
- By:
- Publication type:
- clinical trial
Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia (The following Hospitals and Physicians participated in the study: First Department of Internal Medicine, National University of Athens, Medical School, Laiko General Hospital (D. Loukopoulos, A. M. Tsimberidou, N. Viniou, N. Stavroyianni, J. Meletis, C. Constantopoulos, E. Variami, T. Andreopoulos, Y. Rombos, and X. Yataganas); Department of Clinical Propedeutic National University of Athens Medical School, Laiko General Hospital (P. Panagiotidis); Second Department of Internal Medicine, National University of Athens Medical School, Hippokration General Hospital (Th. Kalmantis and M. Belegrati); Department of Internal Medicine, Division of Hematology,University Hospital of Patras, Rion-Patras (N. Zoumbos, T. Matsouka, M. Tin)
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 7, p. 1721, doi. 10.1002/cncr.11240
- By:
- Publication type:
- Article
Gemcitabine and docetaxel as second-line chemotherapy for patients with nonsmall cell lung carcinoma who fail prior paclitaxel plus platinum-based regimens.
- Published in:
- 2001
- By:
- Publication type:
- journal article